Genenta Science S.p.A.
GNTA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001838716
No open-market purchases or sales by Genenta Science S.p.A. insiders were filed in the last 90 days; 9 institutions reported holding it in 13F filings for Q2 2026, worth $1.33M in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Genenta Science S.p.A. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 6 | 15 | +9 |
| Shares | 552.0K | 2.71M | +2.16M (+391.6%) |
| Value | $1.77M | $4.04M | +$2.28M (+128.9%) |
New holders (9)
Institutions that held Genenta Science S.p.A. at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Eurizon Capital SGR S.p.A. | 360,000 | $536.4K | 0.00% |
| Ghisallo Capital Management LLC | 323,797 | $482.5K | 0.02% |
| Weiss Asset Management LP | 322,026 | $479.8K | 0.01% |
| Norges Bank | 226,178 | $337.0K | 0.00% |
| Alyeska Investment Group, L.P. | 219,838 | $327.6K | 0.00% |
| SmartHarvest Portfolios, LLC | 17,781 | $26.5K | 0.01% |
| UBS Group AG | 3,416 | $5.09K | 0.00% |
| GAMMA Investing LLC | 2,827 | $4.21K | 0.00% |
| Farther Finance Advisors, LLC | 3 | $4 | 0.00% |
Sold out (0)
Institutions that held Genenta Science S.p.A. at the end of Q3 2025 and filed for Q4 2025 without it.
None.